How tirzepatide dosing actually works — and why you cannot calculate it yourself

The biggest myth: that dose is proportional to how much weight you want to lose

It is a reasonable assumption. Stronger medicine, faster result, except that is not how tirzepatide works. The dose ladder exists primarily for tolerability, not potency calibration. Starting too high produces nausea, vomiting and early dropout; starting low allows the gut and central nervous system to adapt. The 2.5 mg pen's job is settling your system, nothing more. Most people do not see significant appetite reduction at that level, which can feel deflating after the first few weeks. That is normal and expected.

The prescriber's job at each review is not to push you up as fast as possible, it is to judge whether you have tolerated the current dose well enough to move, or whether staying put another four weeks is safer. Some people remain on 5 mg or 7.5 mg long-term if that dose achieves good results with minimal side effects. Others titrate to 15 mg. Neither is a failure or a success in isolation. The NHS tirzepatide medicines page explains this titration principle clearly and is worth reading alongside your Patient Information Leaflet.

What this means practically: there is no weight-based formula, no BMI multiplier, no calculation that spits out the right strength. If you have seen tools online claiming to do this, treat them as entertainment rather than clinical guidance.

What the six-strength schedule actually looks like, and what prescribers are watching for

The licensed strengths are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. Each is a separate KwikPen. A prescriber typically increases by one step every four weeks, but only after assessing your reported side-effect burden and (at repeat prescriptions) your weight response. If you are losing well at a middle dose with minimal nausea, there may be no clinical reason to go further. If you are struggling with persistent vomiting, titrating upward would be inappropriate regardless of the schedule.

The prescriber also looks at what you are eating and drinking alongside the medicine. Tirzepatide slows gastric emptying, so fatty or heavily processed meals tend to worsen nausea at higher doses. This means two people on the same dose can have very different experiences depending on diet, hydration and activity, another reason the dose decision is personal rather than formulaic.

For those curious about the mg-to-ml conversion (for instance, if a pen runs out mid-week), our page on tirzepatide mg and ml covers the measurement context in detail. And if you want to see where people typically land across the escalation ladder, the tirzepatide dose overview maps the full schedule with clinical context.

Why online calculators and dose calculators cannot replace a prescriber's assessment

You may have searched for a tirzepatide dosage calculator and found various tools. Some of these can be useful for understanding the schedule in general terms, our own tirzepatide dosage calculator helps people visualise where they are in the escalation sequence. But no calculator can account for whether your nausea is mild enough to warrant an increase this cycle, whether a medication you take could affect how you tolerate a higher dose, or whether a recent change in your health warrants pausing escalation entirely.

A prescriber carrying out a clinical review before every repeat prescription does all of that. At nume, a GPhC-registered Independent Prescriber reviews every repeat personally (not a software system) before any pen is dispensed. That review is what makes dose progression safe rather than automatic. NICE's appraisal of tirzepatide, TA1026, is built on this model of supervised titration; the trial data showing average weight reductions of around 20% at 15 mg came from participants who received exactly that kind of structured clinical oversight, not self-directed dosing.

If you are currently on treatment and wondering whether your dose is right, the most useful thing you can do is record your side-effect experience honestly and bring it to your next review. If you are considering starting, our Mounjaro overview covers eligibility and what the consultation process involves. Questions about what private treatment costs are answered separately on the Mounjaro pricing page.

What to do if you think your dose needs changing

If you are on treatment and feel the current dose is either not working or producing side effects you are finding hard to manage, do not adjust independently. Do not skip an injection, take two pens close together, or cut to a lower-strength pen from a previous prescription without speaking to your prescriber first. None of those adjustments is safe or licensed.

Contact your prescriber or clinical support team. At nume, aftercare is available seven days a week, the contact page has the details. Your prescriber can advise on whether to stay at the current dose longer, reduce temporarily, or address symptoms before the next scheduled increase, and if you want a clearer sense of where you currently sit in the escalation sequence, our Mounjaro golden dose calculator can help you think that through before your next appointment. The general FAQs also cover common questions that come up between appointments.

If you have not yet started treatment and want to understand whether you are eligible, the route is a free consultation, reviewed the same day by a named prescriber. Start your free consultation to find out where you stand clinically.